Smart Pills Technology Market 2019: Global Overview, Key Players Analysis, Sales Revenue, Development Status, Future Trends, Opportunities and Industry Expansion Strategies 2025
Smart Pills Technology Market from Qurate Business Intelligence provides detailed information, in depth analysis and forecast which is developed by team of experts and professionals.
(EMAILWIRE.COM, January 08, 2019 ) Global Smart Pills Technology Industry was valued at USD 2.6 Billion in the year 2017. Global Smart Pills Technology Industry is further estimated to grow at a CAGR of 21% from 2019 to reach USD 12.02 Billion by the year 2025. The smart pill is a wireless capsule that can be swallowed, and with the help of a receiver (worn by patients) and software that analyzes the pictures captured by the smart pill, the physician is effectively able to examine the gastrointestinal tract.
The global Smart Pills Technology Industry is segmented on the basis of technology, disease indication and by region. On the basis of technology, the Industry is segmented Capsule Endoscopy, Patient Monitoring and Drug Delivery of which Capsule Endoscopy segment is expected to hold the highest Industry share during the forecast period and are expected to grow with highest CAGR. On the basis of Disease Indications, the Industry is segmented as Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes and Others in which Occult GI Bleeding segment holds the highest Industry share in the forecasted period.
Get Free Sample Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-GRS-RCG-134329
SWOT Analysis of Smart Pills Technology Industry:
Strength:
Increasing Preference for Minimally Invasive Device.
Technological Advancements in Capsule Endoscopes.
Rise in Incidences of Colon Cancer.
Weakness:
Technological Incompetence of Capsule Endoscopes.
Ethical Constraints.
Opportunities:
Need for Rapid Drug Development Process.
Threats:
Potential Health Risks.
Increasing Cost with Technological Advancement.
Given Imaging Inc., Olympus Corporation, CapsoVision Inc., Bio-Images Research Ltd., Boston Scientific Corp., Ge Healthcare, Novartis AG and other 10 more companies’ detailed information is provided in the report. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/RCG/QBI-GRS-RCG-134329
Smart Pills Technology Industry Segmentation:
By Disease Indications
• Occult GI Bleeding
• Crohn’s Disease
• Small Bowel Tumors
• Celiac Disease
• Inherited Polyposis Syndromes
• Others
By Technology
• Capsule Endoscopy
o Small Bowel Video Capsule Endoscopy
o Colon Capsule Endoscopy
• Patient Monitoring
• Drug Delivery
By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa
Purchase Report@ https://www.qurateresearch.com/report/buy/RCG/QBI-GRS-RCG-134329/
The global Smart Pills Technology Industry is segmented on the basis of technology, disease indication and by region. On the basis of technology, the Industry is segmented Capsule Endoscopy, Patient Monitoring and Drug Delivery of which Capsule Endoscopy segment is expected to hold the highest Industry share during the forecast period and are expected to grow with highest CAGR. On the basis of Disease Indications, the Industry is segmented as Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes and Others in which Occult GI Bleeding segment holds the highest Industry share in the forecasted period.
Get Free Sample Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-GRS-RCG-134329
SWOT Analysis of Smart Pills Technology Industry:
Strength:
Increasing Preference for Minimally Invasive Device.
Technological Advancements in Capsule Endoscopes.
Rise in Incidences of Colon Cancer.
Weakness:
Technological Incompetence of Capsule Endoscopes.
Ethical Constraints.
Opportunities:
Need for Rapid Drug Development Process.
Threats:
Potential Health Risks.
Increasing Cost with Technological Advancement.
Given Imaging Inc., Olympus Corporation, CapsoVision Inc., Bio-Images Research Ltd., Boston Scientific Corp., Ge Healthcare, Novartis AG and other 10 more companies’ detailed information is provided in the report. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/RCG/QBI-GRS-RCG-134329
Smart Pills Technology Industry Segmentation:
By Disease Indications
• Occult GI Bleeding
• Crohn’s Disease
• Small Bowel Tumors
• Celiac Disease
• Inherited Polyposis Syndromes
• Others
By Technology
• Capsule Endoscopy
o Small Bowel Video Capsule Endoscopy
o Colon Capsule Endoscopy
• Patient Monitoring
• Drug Delivery
By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa
Purchase Report@ https://www.qurateresearch.com/report/buy/RCG/QBI-GRS-RCG-134329/
Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results